| AMGN Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the AMGN market cap history going back to 2/12/2010:
Also see: AMGN Shares Outstanding History and AMGN YTD Return |
AMGN Market Cap History — Amgen Capitalization Over Time
As of 4/27/2026 Amgen has a market cap of 183.60 billion. Investors often follow the AMGN market cap history to compare the size of the company over time.
This page shows AMGN market capitalization trends over time, with 67 market cap datapoints presented, dating back to 2/12/2010.
| AMGN Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
AMGN Historical Market Cap: +7.68% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| AMGN Stock Price Chart |
| About Amgen Inc |
| Amgen Inc. is a biotechnology company dedicated to discovering, developing, manufacturing, and delivering human therapeutics. It focuses on addressing high unmet medical needs to enhance health outcomes and improve lives. Operating primarily in the human therapeutics segment, Amgen's extensive portfolio includes well-known products such as Aranesp, ENBREL, Prolia, Neulasta, Otezla, and Repatha, among others. These therapies target various conditions, showcasing Amgen's commitment to leveraging its expertise in biotechnology to provide innovative solutions for patients. We show 67 historical shares outstanding datapoints in our AMGN shares outstanding history coverage, used to compute AMGN market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing AMGN market cap history over the course of time is important for investors interested in comparing AMGN's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of AMGN versus a peer is one thing; comparing AMGN market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like AMGN can fluctuate over the course of history. With this page we aim to empower investors researching AMGN by allowing them to research the AMGN market cap history. |
| AMGN Current Stock Quote |
Quotes delayed 20 minutes  Free AMGN Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| AMGN Share Performance |
| Market Cap Peers |
| Amgen (AMGN) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
AMIX Market Cap History AMLX Market Cap History AMN Market Cap History AMPH Market Cap History AMRX Market Cap History AMTI Market Cap History ANAB Market Cap History ANAC Market Cap History ANEB Market Cap History ANGN Market Cap History More Healthcare companies » |
AMGN Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
